The metabolic syndrome and type 2 diabetes: What has gone wrong in type 2 diabetes care?

被引：2
|
作者：
Werner K. Waldhäusl
机构：
[1] Medical University of Vienna,Department of Medicine III, Division of Endocrinology & Metabolism
来源：
Current Diabetes Reports | 2004年 / 4卷 / 6期
关键词：
Metabolic Syndrome; Metformin; Diabetes Research; Multifactorial Intervention; Health Insurance Premium;
D O I：
10.1007/s11892-004-0043-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：395 / 396
页数：1
相关论文
共 50 条
  • [41] Inflammatory Overtones of Organokines in Metabolic Syndrome and Type 2 Diabetes
    Guria, Suktara
    Basu, Soumyadeep
    Hoory, Anupama
    Mukherjee, Sutapa
    Mukhopadhyay, Satinath
    JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE, 2023, 103 (01) : 103 - 121
  • [42] The role of adipokines in the development of metabolic syndrome and type 2 diabetes
    Tobe, K
    Kadowaki, T
    CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 95 - 96
  • [43] Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
    Matikainen, Niina
    Taskinen, Marja-Riitta
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (06) : 721 - 731
  • [44] New drug targets for type 2 diabetes and the metabolic syndrome
    David E. Moller
    Nature, 2001, 414 : 821 - 827
  • [45] The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong, J.
    Molyneaux, L.
    Constantino, M. I.
    Twigg, S. M.
    Yue, D. K.
    DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 690 - 697
  • [46] Type 2 diabetes mellitus, metabolic syndrome and change in lifestyle
    Portero Mclellan, Katia Cristina
    Barbalho, Sandra Maria
    Cattalini, Marino
    Lerario, Antonio Carlos
    REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION, 2007, 20 (05): : 515 - 524
  • [47] Central obesity, metabolic syndrome and type 2 diabetes mellitus
    Pusparini
    UNIVERSA MEDICINA, 2007, 26 (04) : 195 - 204
  • [48] Metabolic syndrome in subjects with type-2 diabetes mellitus
    Alebiosu, CO
    Odusan, BA
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (06) : 817 - 821
  • [49] Focus on type 2 diabetes, metabolic syndrome and cardiovascular risk
    POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER, 2010, 274 : 20 - 25
  • [50] THE PROGNOSTIC IMPACT OF METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES
    Sato, A.
    Fujikawa, H.
    Yanou, W.
    Babazono, T.
    JOURNAL OF HYPERTENSION, 2019, 37 : E265 - E265
12345